Association of 9-hydroxy risperidone concentrations with risk of switching or discontinuation in the clinical antipsychotic trial of intervention effectiveness-alzheimer's disease trial / Alette M. Wessels en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 6 (Diciembre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 6 (Diciembre) . - pp. 683-687 Título : Association of 9-hydroxy risperidone concentrations with risk of switching or discontinuation in the clinical antipsychotic trial of intervention effectiveness-alzheimer's disease trial Tipo de documento: texto impreso Autores: Alette M. Wessels, Autor ; Bruce G. Pollock, Autor ; Norbert G. Anyama, Autor Fecha de publicación: 2022 Artículo en la página: pp. 683-687 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Enfermedad de Alzheimer, Suspensión del tratamiento, 9-OH risperidona Resumen: Risperidone has been used to treat behavioral symptoms, such as delusions and agitation, in people with Alzheimer's disease. The relationship between magnitude and variability of risperidone and 9-hydroxy risperidone exposure and the relationship with time to discontinuation of the medication were explored. Link: ./index.php?lvl=notice_display&id=29416 [artículo] Association of 9-hydroxy risperidone concentrations with risk of switching or discontinuation in the clinical antipsychotic trial of intervention effectiveness-alzheimer's disease trial [texto impreso] / Alette M. Wessels, Autor ; Bruce G. Pollock, Autor ; Norbert G. Anyama, Autor . - 2022 . - pp. 683-687. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 6 (Diciembre) . - pp. 683-687 Palabras clave: Enfermedad de Alzheimer, Suspensión del tratamiento, 9-OH risperidona Resumen: Risperidone has been used to treat behavioral symptoms, such as delusions and agitation, in people with Alzheimer's disease. The relationship between magnitude and variability of risperidone and 9-hydroxy risperidone exposure and the relationship with time to discontinuation of the medication were explored. Link: ./index.php?lvl=notice_display&id=29416

---

1 (1 - 1 / 1)